1990
DOI: 10.1210/jcem-71-6-1602
|View full text |Cite
|
Sign up to set email alerts
|

Brain Glucose Metabolism in Noninsulin-Dependent Diabetes Mellitus: A Study in Pima Indians Using Positron Emission Tomography during Hyperinsulinemia with Euglycemic Glucose Clamp

Abstract: To determine whether insulin or noninsulin-dependent diabetes mellitus affects brain glucose metabolism, brain glucose utilization was studied in the basal state and during hyperinsulinemic euglycemic glucose clamps in nondiabetic and diabetic Pima Indians by positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose (18FDG). Glucose utilization in 75 brain areas was determined by analysis of single scans and by least squares estimation of the rate parameters for the FDG model; these data were compared … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
11
0

Year Published

2000
2000
2011
2011

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 31 publications
(12 citation statements)
references
References 60 publications
(75 reference statements)
1
11
0
Order By: Relevance
“…In an early FDG-PET study in humans, a small sample of Pima Indians with T2D (n=4) showed no overall differences compared with caucasian participants without T2D 20. Regional differences were not examined, however, and the diabetic group was heterogenous with respect to treatment.…”
Section: Discussionmentioning
confidence: 99%
“…In an early FDG-PET study in humans, a small sample of Pima Indians with T2D (n=4) showed no overall differences compared with caucasian participants without T2D 20. Regional differences were not examined, however, and the diabetic group was heterogenous with respect to treatment.…”
Section: Discussionmentioning
confidence: 99%
“…It has also been applied to an earlier study in humans showing that neither blood-to-brain glucose transport nor cerebral glucose metabolism is reduced in poorly controlled type 1 diabetes (24). It differs from other PET methods (42)(43)(44) in that it uses both [ 11 C]glucose labeled in the C-1 position and a model that includes a fourth rate constant to account for the egress of […”
Section: Discussionmentioning
confidence: 99%
“…Conversely, chronic hyperglycaemia is a de®ning characteristic of Type 2 diabetes, and it is likely that the link between diabetes and CNS dysfunction is mediated by the family of metabolic derangements associated with chronically elevated blood glucose levels [34,35]. Regional cerebral blood¯ow often decreases during chronic (and acute) hyperglycaemia in animals [36], and abnormalities in brain uptake and metabolism of glucose have been reported inconsistently in older adults with Type 2 diabetes [37,38]. Aminergic neurotransmitter pathways (including norepinephrine, dopamine and serotonin) are also known to be affected by diabetes, but again virtually all of these studies have been conducted on animal models of diabetes (for reviews see McCall [39]).…”
Section: Hyperglycaemia-associated Pathophysiological Mechanismsmentioning
confidence: 99%